MiniMed Group Cash Flow Statement

Financials in millions USD. Fiscal year is May - April.

Millions USD. Fiscal year is May - Apr.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023
Period Ending	Jan '26 Jan 23, 2026	Apr '25 Apr 25, 2025	Apr '24 Apr 26, 2024	Apr '23 Apr 28, 2023
Net Income	-300	-198	-107	-92
Depreciation & Amortization	155	143	129	115
Stock-Based Compensation	47	41	38	35
Other Adjustments	53	32	54	28
Change in Receivables	-124	-66	-105	-70
Changes in Inventories	-71	-19	5	-28
Changes in Accounts Payable	161	191	-4	14
Changes in Other Operating Activities	50	16	30	-6
Operating Cash Flow	56	140	41	-6
Operating Cash Flow Growth	36.59%	241.46%	-	-
Capital Expenditures	-224	-193	-148	-167
Purchases of Investments	-	-	-5	-13
Proceeds from Sale of Investments	-	-	11	-
Other Investing Activities	-10	-	-14	-
Investing Cash Flow	-234	-193	-157	-180
Other Financing Activities	179	10	112	185
Financing Cash Flow	179	10	112	185
Net Cash Flow	1	-43	-4	-1
Free Cash Flow	-168	-53	-107	-173
FCF Margin	-5.62%	-1.95%	-4.33%	-7.71%
Free Cash Flow Per Share	-0.66	-0.21	-	-
Levered Free Cash Flow	-168	-75	-100	-168
Unlevered Free Cash Flow	-230	-59.65	-94.46	-155.53

Updated Apr 17, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q